Immix Biopharma, Inc. · NASDAQ:IMMX
Immix Biopharma, Inc. shareholders
As of Sep 30, 2026, 133 institutions reported holding Immix Biopharma, Inc., 78.6% of its shares. Largest: Janus Henderson, Eventide Asset Management, LLC and Saturn V Capital Management LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Immix Biopharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Janus Henderson | 12.1M | 14.4% | first report | Nov 16, 2026 |
| Eventide Asset Management, LLC | 5.19M | 6.2% | +1.3M | Nov 13, 2026 |
| Saturn V Capital Management LP | 4.66M | 5.6% | +2,686 | Nov 16, 2026 |
| BlackRock | 4.54M | 5.4% | +1.55M | Nov 13, 2026 |
| Vanguard | 4.1M | 4.9% | +879K | Nov 13, 2026 |
| State Street | 3.3M | 3.9% | +307K | Nov 12, 2026 |
| Opaleye Management Inc. | 2.83M | 3.4% | +480K | Nov 16, 2026 |
| Balyasny Asset Management L.P. | 2.64M | 3.2% | +2.23M | Nov 16, 2026 |
| Ameriprise | 1.86M | 2.2% | +1.34M | Nov 16, 2026 |
| Marshall Wace, LLP | 1.85M | 2.2% | +59,307 | Nov 13, 2026 |